Fox Chase Cancer Center News

Temple Health’s Fox Chase Cancer Center, one of only 57 NCI-designated comprehensive cancer centers, announced a new clinical trial collaboration with Labcorp, a global leader of innovative and comprehensive laboratory services. The study will evaluate Labcorp Plasma Detect Genome MRD, a highly sensitive, tumor-informed, whole-genome sequencing-based test, to assess risk of recurrence in patients with early-stage non-small cell lung cancer.

At Fox Chase Cancer Center, Brendan Boyle, a Democrat representing Pennsylvania’s Second Congressional District, joined clinicians, researchers, and advocates to highlight growing national momentum around lung cancer in women, an area receiving increased attention through the bipartisan Women and Lung Cancer Research and Preventive Services Act.

One hundred and forty-four (144) Fox Chase Cancer Center physicians have been named to Philadelphia magazine’s “Top Doctors” list for 2026. Physicians on the list were nominated by a national survey of their professional peers.

Calling all dog lovers! Registration is now open for this year’s Paws for the Cause, presented by Fox Chase Cancer Center’s Board of Associates. Fundraising officially kicked off this March for the well-loved dog walk, set for Sunday, September 20, 2026.

Temple Health today announced the appointment of Robert A. Winn, MD, as the next Cancer Center Director for Fox Chase Cancer Center, marking a defining moment that will shape the future of one of the nation’s leading National Cancer Institute-designated Comprehensive Cancer Centers.

On October 29, 2025, Jay Simhan, MD, FACS, was installed as the inaugural Carol and Louis Della Penna Chair in Urologic Cancer Survivorship at a ceremony hosted by Temple University, Fox Chase Cancer Center, and Temple Health.

Unlike conventional radiation therapy systems, adaptive radiotherapy creates a new plan for each treatment session, allowing clinicians to deliver larger doses of radiation to tumors more safely.

By aligning treatment with patients’ values and goals, Fox Chase Cancer Center clinicians are infusing Goal Concordant Care into routine practice, partnering with their patients to honor what matters most when facing serious illness.